Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Recombinant Human Hyaluronidase (800/1600/2400) / Subcutaneous Immunoglobulin-G (10/20/30), secondary antibody deficiency, hematologic neoplasms, stem cell transplantation, cycle 1

Protocol-ID: 1722 V1.0 (Mini), RHUH(800/1600/2400)/SCIgG(10/20/30), Sec. Antibody Deficiency, hemat. Neoplasia, C1

Indication(s)

  • Antibody Deficiency, Secondary to Hematological Neoplasms / after Stem Cell Transplantation; ICD-10 D80.9

Links

  • prescribing information for Recombinant Human Hyaluronidase (HYQVIA) (FDA) [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 12.03.2021